Insulet (PODD) - 2023 Q1 - Earnings Call Transcript

Matt, itÂ's Wayde. Happy to take that and I think Jim covered it well, but maybe just a couple things I could add to that. I think as Jim said, one of the best indicators we have is that there are some type 1 endocrinologists that are already have more than 70% of their type 1s on a pump. So thatÂ's a clear early indicator. But itÂ's a great question on the rate of change. WeÂ'll see how that market develops. The good news is we have many other growth platforms, obviously our leadership position in type 2 i ...